• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    Osiris Therapeutics, Inc. (OSIR)

    -NasdaqGM
    16.88 Down 0.02(0.12%) 4:00PM EST
    |After Hours : 16.88 0.00 (0.00%) 4:50PM EST
    Add to Portfolio
    Prev Close:16.90
    Open:16.61
    Bid:N/A
    Ask:17.79 x 400
    1y Target Est:17.33
    Beta:0.04
    Earnings Date:Mar 3 - Mar 9 (Est.)
    Day's Range:16.61 - 17.05
    52wk Range:11.80 - 17.60
    Volume:53,156
    Avg Vol (3m):118,645
    Market Cap:579.32M
    P/E (ttm):12.22
    EPS (ttm):1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OSIR

    Comparison

    Symbol% ChgMkt Cap
    OSIRDown 0.12%579.32M
    ABTDown 1.06%65.77B
    BIIBDown 1.26%84.52B

    Key Statistics

    Forward P/E (1 yr):76.73
    P/S (ttm):11.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.02
    Quarterly EPS Est (Dec-14) :0.05
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing products to treat medical conditions in wound care, orthopedic, and sports medicine markets. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback